Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Ordinary Shares Nominal value of NIS 0.0000769 per share
-
Shares outstanding
-
45.5M
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
7.51M
-
Shares change
-
+2.19M
-
Total reported value, excl. options
-
$15.9M
-
Value change
-
+$4.69M
-
Put/Call ratio
-
0
-
Number of buys
-
7
-
Number of sells
-
-6
-
Price
-
$2.12
Significant Holders of Entera Bio Ltd. - Ordinary Shares Nominal value of NIS 0.0000769 per share (ENTX) as of Q4 2024
22 filings reported holding ENTX - Entera Bio Ltd. - Ordinary Shares Nominal value of NIS 0.0000769 per share as of Q4 2024.
Entera Bio Ltd. - Ordinary Shares Nominal value of NIS 0.0000769 per share (ENTX) has 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.51M shares
of 45.5M outstanding shares and own 16.51% of the company stock.
Largest 10 shareholders include Knoll Capital Management, LLC (5.88M shares), Schonfeld Strategic Advisors LLC (632K shares), Parkman Healthcare Partners LLC (414K shares), NORTHERN TRUST CORP (212K shares), Perigon Wealth Management, LLC (146K shares), RENAISSANCE TECHNOLOGIES LLC (61.8K shares), SIGNATURE ESTATE & INVESTMENT ADVISORS LLC (47.3K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (38.4K shares), GEODE CAPITAL MANAGEMENT, LLC (21.1K shares), and HighTower Advisors, LLC (11.8K shares).
This table shows the top 15 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.